Connecticut AG William Tong and the Connecticut Office of Consumer Counsel entered into a proposed settlement with Charter, Cox Communications, and Cox Enterprises in connection with Charter’s change-of-control application before the Connecticut Public Utilities Regulatory Authority as a result of Charter’s acquisition of Cox operations in the state.

Read More

Iowa AG Brenna Bird filed a lawsuit against multiple pharmacy benefit managers (PBMs) and insulin manufacturers, alleging the companies violated Iowa’s Consumer Fraud Act by artificially inflating diabetes drug prices for Iowa consumers. According to the petition, the PBMs and manufacturers allegedly engaged in an unlawful pricing scheme that substantially increased the price of insulin…

Read More

The Federal Trade Commission issued warning letters to 42 law firms regarding potential antitrust concerns tied to participation in Diversity Lab’s “Mansfield Certification” program, citing risks of competitor coordination in labor markets. In the letter, the FTC highlighted the program’s benchmark encouraging firms to consider candidate pools that are at least 30% “underrepresented” lawyers for…

Read More

A bipartisan coalition of 23 AGs and several state banking regulators submitted a comment letter urging the OCC to withdraw two proposals addressing mortgage escrow accounts—an escrow rule and a related preemption determination that would preempt certain state laws requiring national banks to pay minimum interest on mortgage escrow accounts. In the letter, the states…

Read More

A coalition of 48 AGs led by Connecticut AG William Tong reached separate settlements with Lannett Company, Inc. (“Lannett”) and Bausch Health US, LLC/Bausch Health Americas, Inc. (“Bausch”) in generic-drug antitrust litigation. The states allege the companies participated in long-running conspiracies to fix prices and otherwise restrain competition in the generic drug market, including through…

Read More